Gaush Medical Group is a company committed to advancing patients’ eye health. With more than 20 years of development, Gaush has now become an integrated platform provider with core business covering R&D, manufacturing, sales, training, and technical services of ophthalmic devices. Product Portfolio With continuous expansion, Gaush has achieved a rich product portfolio that covers all 4 major dimensions of ophthalmic devices (diagnosis, treatment, instruments, consumables). With more than 120 types of products, Gaush aims at addressing the various needs of ophthalmologists and patients in 7 sub-specialties of eye health (Retinal Disease, Cataract, Glaucoma, Refractive Surgery, Optometry, Ocular Surface / Corneal Disease, and Pediatric Ophthalmology). International Brand Partnerships Professionalism, integrity, and accountability form the basis of the long-term cooperation between Gaush and international brand partners. Around 20 globally influential ophthalmic players from Germany, UK, France, US, Japan etc. have established exclusive partnerships with Gaush for China market. Gaush is capable to perform a role of connecting China’s ophthalmic industry with global standard, and introducing more high-quality choices of care to domestic patients. Research and Development To maintain a long-term competitiveness in research and development, Gaush has developed a number of subsidiaries with distinct strengths on different branches of the ophthalmic device industry. The company owns 2 R&D centers abroad (in the Netherlands and Germany) focusing on premium IOL and electrophysiological systems respectively, also 5 domestic centers that develop ophthalmic diagnosis equipment, surgical instrument, ophthalmic consumables and implants, etc. By enhancing technological competency, enriching product mix, improving patients’ visions and quality of lives, Gaush has been striding forward to become a leading ophthalmic total solution provider with global impact.